Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis
Verdict: BUY
Aggressive CEO insider buying and a pivot to profitability face headwinds from recent analyst downgrades and price target compression.
Investment score: 68/100
Analysis as of
Is Aurinia Pharmaceuticals Inc stock worth reviewing? The TradeMates thesis
The model views AUPH as a high-quality biotech transition story. While the company has achieved profitability and massive insider support, the technical trend is currently negative and analyst revisions are trending downward. A 'Hold' is suggested until price stabilizes above $16.00.
7-factor investment score
- Valuation: 72/100 (weight 20%)
- Financial Health: 85/100 (weight 15%)
- Technical Momentum: 45/100 (weight 15%)
- Earnings Quality: 80/100 (weight 15%)
- Insider Sentiment: 95/100 (weight 10%)
- Analyst Consensus: 40/100 (weight 10%)
- Risk-Adjusted Return: 60/100 (weight 15%)
Aurinia Pharmaceuticals Inc opportunities and risks
What speaks for AUPH
- Aggressive Insider Buying Clusters
What speaks against AUPH
- Analyst Sentiment Decoupling
Peers and competitors
- XENE
- ABUS
- EPRX.TO
- EDT.TO
- ZYME
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| AUPH | 6.8x | 6.5x | 12.2x | 89.7% | 100.0% | 8.5% |
| XENE | n/a | 0.0x | n/a | 0.0% | 0.0% | -4.9% |
| ABUS | 5.3x | 4.6x | 5.3x | 100.0% | 84.0% | -3.9% |
| EPRX.TO | n/a | 0.0x | n/a | 0.0% | 0.0% | -14.5% |
| EDT.TO | n/a | 145.6x | n/a | -79.2% | -1377.2% | -2.8% |
| ZYME | n/a | 20.5x | n/a | 94.4% | -126.3% | -4.6% |
| Peer median | n/a | 4.6x | n/a | 0.0% | 0.0% | -4.6% |
Frequently asked questions about Aurinia Pharmaceuticals Inc (AUPH)
Is AUPH stock a good investment?
The TradeMates model rates Aurinia Pharmaceuticals Inc as BUY with an investment score of 68/100. The model views AUPH as a high-quality biotech transition story. While the company has achieved profitability and massive insider support, the technical trend is currently negative and analyst revisions are trending downward. A 'Hold' is suggested until price stabilizes above $16.00. This is algorithmic model output, not personal investment advice.
Is AUPH stock a buy?
The TradeMates model verdict for AUPH is BUY with an investment score of 68/100. Treat this as a model signal to review, not a personal buy recommendation.